Many US rheumatologists fail to follow ACR gout guidelines for urate lowering drug dosage

Gout Management: Are We Missing the Mark on Urate-Lowering Dosage?

Gout, a painful form of inflammatory arthritis, is on the rise. Effective management hinges on lowering uric acid levels in the blood, but recent findings suggest a potential gap between recommended guidelines and real-world practice.

Understanding Gout and Urate-Lowering Therapy

Gout occurs when uric acid, a natural waste product, builds up in the blood and forms crystals that deposit in joints, triggering intense pain, inflammation, and swelling.

Urate-lowering therapy (ULT) is the cornerstone of long-term gout management. These medications, such as allopurinol and febuxostat, work by reducing the production of uric acid. The goal of ULT is to lower and maintain serum urate levels below a target of 6 mg/dL.

Study Highlights Discrepancies in Urate-Lowering Dosage

A recent study published in The Journal of Rheumatology reveals that while many rheumatologists report generally adhering to the American College of Rheumatology (ACR) guidelines for gout management, a notable divergence exists regarding the dosage of urate-lowering medications.

“The management of gout remains suboptimal because of the lack of adherence to treatment recommendations by health care providers, patients’ poor understanding of the disease and its management or both,” wrote Naomi Schlesinger, MD, of the University of Utah’s Spencer Fox Eccles School of Medicine, and colleagues.

Rheumatologists report largely adhering to ACR guidelines for gout management but show notable divergence with the recommended dosages of urate-lowering therapies, according to data._Image: Adobe Stock

This suggests that some patients may not be receiving a sufficient dose to effectively lower their uric acid levels to the recommended target, potentially leading to continued pain, flares, and joint damage.

Why is Dosage So Important?

Achieving the target serum urate level is crucial for resolving gout symptoms and preventing long-term complications. Insufficient dosage can result in:

  • Persistent flares: Continuing pain and inflammation.
  • Joint damage: Chronic inflammation can erode cartilage and bone.
  • Tophi formation: Uric acid crystals can accumulate under the skin, forming visible nodules.
  • Kidney problems: High uric acid levels can damage the kidneys.